News

Interventional Cardiology Completes First Angiovac Case

BRIGHTON – Lawrence Garcia, MD, chief of Interventional Cardiology, and a team of clinicians from the Cardiac Cath Lab, completed St. E’s first endovascular large burden clot removal using the Angiovac system by Vortex Inc. in November. The Angiovac system is designed to allow interventionalists to remove a large amount of thrombus that may be acute, sub-acute or as in this case chronic through this large bore device “in short order,” said Garcia.

Garcia led a team in declotting and removal of thrombus from a patient’s inferior vena cava and iliac vein in just a few hours. St. E’s is one only four hospitals in Massachusetts that uses this technology, which provides an effective rapid treatment for patients with large burden thrombus such as in the inferior vena cava and iliac vein, proximal pulmonary emboli or thrombus in transit in a cardiac chamber. Angiovac provides an efficient and safe alternative to treating clots with thrombolytic agents, which works slowly over longer periods of time or in those patients that cannot receive thrombolytic therapy, or emergency surgery.

Pulmonary embolism and venous thromboembolism pose a large burden to the health care system, with about 300,000 to 660,000 new cases per year in the United States. Even if the clot does not travel to the lung or heart and cause death, a large clot in the leg or cava can cause chronic ulceration, post-thrombotic syndrome, and chronic venous insufficiency. Additionally, clots that remain in the vasculature can cause chronic pulmonary hypertension.

In addition to Garcia and staff from the Division of Interventional Cardiology, anesthesiologists, nursing staff and technologists played key roles in the success of St. E’s first Angiovac case. “This is a great example of cooperation between services that is critical to making our institution a local and world leader in patient care,” Garcia said.

To learn more, please contact Dr. Garcia at 617-789-5027.

About St. Elizabeth’s Medical Center

St. Elizabeth’s Medical Center, a Thompson Reuters Top 100 Hospital, is a major academic medical center affiliated with Tufts University School of Medicine. Areas of medical excellence include cardiology, neurosciences, bariatric surgery, women’s health, high-risk obstetrics, bone and joint health, hematology/oncology, pulmonary medicine and emergency medicine. St. Elizabeth’s is a member of Steward Health Care, which is the second largest health care system in New England. Visit St. Elizabeth’s online at StewardStElizabeths.org.

About Steward Health Care

Steward Health Care is a community-based accountable care organization and the parent company of Caritas Christi Health Care. Headquartered in Boston, Steward has more than 13,000 employees serving more than one million patients annually in 85 communities. Hospitals in the system include Saint Anne’s Hospital in Fall River, Holy Family Hospital in Methuen, St. Elizabeth’s Medical Center in Brighton, Norwood Hospital, Carney Hospital in Dorchester, Merrimack Valley Hospital in Haverhill, Nashoba Valley Medical Center in Ayer, Good Samaritan Medical Center in Brockton, Morton Hospital in Taunton and Quincy Medical Center. Other Steward Health Care entities include Steward Physician Network, Steward Hospice and Home Care, Labouré College and Por Cristo. Further information is available at www.Steward.org.

Contact Info

info@catalysthealthventures.com

(781) 228-5228

50 Braintree Hill Office Park
Suite 301
Braintree, MA 02184